204 related articles for article (PubMed ID: 6947981)
1. Anti-Ia reactivity in sera from patients with systemic lupus erythematosus.
Okudaira K; Searles RP; Ceuppens JL; Goodwin JS; Williams RC
J Clin Invest; 1982 Jan; 69(1):17-24. PubMed ID: 6947981
[TBL] [Abstract][Full Text] [Related]
2. Anti-Ia reactivity in sera from subjects with Entamoeba histolytica infection.
De Simone C; Cilli A; Zanzoglu S; Vullo V; Delia S; Sorice F
Trans R Soc Trop Med Hyg; 1984; 78(1):64-8. PubMed ID: 6200968
[TBL] [Abstract][Full Text] [Related]
3. Surface antigen specificity of cold-reactive IgM antilymphocyte antibodies in systemic lupus erythematosus.
Yamada A; Shaw M; Winfield JB
Arthritis Rheum; 1985 Jan; 28(1):44-51. PubMed ID: 2578282
[TBL] [Abstract][Full Text] [Related]
4. Ia specific antilymphocyte antibodies in rheumatoid arthritis.
Searles RP; Okudaira K; Savage SM; Goodwin JS
Arthritis Rheum; 1983 Apr; 26(4):486-93. PubMed ID: 6340699
[TBL] [Abstract][Full Text] [Related]
5. OKT4+ T cell abnormality in patients with active systemic lupus erythematosus: HLA-DR antigen expressions.
Raziuddin S; Danial HB; Kelley M
Clin Immunol Immunopathol; 1988 Jul; 48(1):42-9. PubMed ID: 3260161
[TBL] [Abstract][Full Text] [Related]
6. T lymphocyte interaction with immunoglobulin G antibody in systemic lupus erythematosus.
Okudaira K; Searles RP; Tanimoto K; Horiuchi Y; Williams RC
J Clin Invest; 1982 Apr; 69(4):1026-38. PubMed ID: 6978891
[TBL] [Abstract][Full Text] [Related]
7. Characterization of warm-reactive IgG anti-lymphocyte antibodies in systemic lupus erythematosus. Relative specificity for mitogen-activated T cells and their soluble products.
Litvin DA; Cohen PL; Winfield JB
J Immunol; 1983 Jan; 130(1):181-6. PubMed ID: 6600174
[TBL] [Abstract][Full Text] [Related]
8. Functional property of Ia-positive T cells in peripheral blood from patients with systemic lupus erythematosus.
Koide J
Scand J Immunol; 1985 Nov; 22(5):577-84. PubMed ID: 3878581
[TBL] [Abstract][Full Text] [Related]
9. Serum antibodies to human leucocyte antigen (HLA)-E, HLA-F and HLA-G in patients with systemic lupus erythematosus (SLE) during disease flares: Clinical relevance of HLA-F autoantibodies.
Jucaud V; Ravindranath MH; Terasaki PI; Morales-Buenrostro LE; Hiepe F; Rose T; Biesen R
Clin Exp Immunol; 2016 Mar; 183(3):326-40. PubMed ID: 26440212
[TBL] [Abstract][Full Text] [Related]
10. Antibodies to HLA-E in nonalloimmunized males: pattern of HLA-Ia reactivity of anti-HLA-E-positive sera.
Ravindranath MH; Kaneku H; El-Awar N; Morales-Buenrostro LE; Terasaki PI
J Immunol; 2010 Aug; 185(3):1935-48. PubMed ID: 20610644
[TBL] [Abstract][Full Text] [Related]
11. Characterization of the alloactivated E+Ia+ cell capable of stimulating in mixed lymphocyte culture.
Shen HH; Irigoyen O; Friedman SM; Chess L
J Immunol; 1982 Jan; 128(1):501-5. PubMed ID: 6459379
[TBL] [Abstract][Full Text] [Related]
12. Relationship of anti-beta 2-microglobulin antibodies to T11 and T-cell activation in systemic lupus erythematosus.
Croghan TW; Minota S; Yamada A; Winfield JB
Clin Immunol Immunopathol; 1985 Nov; 37(2):179-90. PubMed ID: 3899432
[TBL] [Abstract][Full Text] [Related]
13. "Anti-Ia reactivity in sera from patients with chronic active hepatitis (CAH)".
Levrero M; Barnaba V; Paroli M; Valesini G; Franco A; Laghi V; Cauda R; Balsano F
J Clin Lab Immunol; 1987 Oct; 24(2):63-8. PubMed ID: 2963916
[TBL] [Abstract][Full Text] [Related]
14. Presence of complement-fixing anti-endothelial cell antibodies in systemic lupus erythematosus.
Cines DB; Lyss AP; Reeber M; Bina M; DeHoratius RJ
J Clin Invest; 1984 Mar; 73(3):611-25. PubMed ID: 6368583
[TBL] [Abstract][Full Text] [Related]
15. Increased frequency of class I and II anti-human leukocyte antigen antibodies in systemic lupus erythematosus and scleroderma and associated factors: a comparative study.
Tozkir H; Pamuk ON; Duymaz J; Gurkan H; Yazar M; Sari G; Tanrikulu H; Pamuk GE
Int J Rheum Dis; 2016 Dec; 19(12):1304-1309. PubMed ID: 25292400
[TBL] [Abstract][Full Text] [Related]
16. Studies on human blood lymphocytes with iC3b (type 3) complement receptors. I. Granular, Fc-IgG receptor positive and negative subsets in healthy subjects and patients with systemic lupus erythematosus.
Bakke AC; Gray JD; Abo W; Quismorio FP; Lash A; Cooper SM; Horwitz DA
J Immunol; 1986 Feb; 136(4):1253-9. PubMed ID: 2935574
[TBL] [Abstract][Full Text] [Related]
17. Augmentation of anti-HLA-E antibodies with concomitant HLA-Ia reactivity in IFNγ-treated autologous melanoma cell vaccine recipients.
Ravindranath MH; Selvan SR; Terasaki PI
J Immunotoxicol; 2012; 9(3):282-91. PubMed ID: 22283601
[TBL] [Abstract][Full Text] [Related]
18. In vitro effect of thymosin on T-lymphocyte rosette formation in rheumatic diseases.
Moutsopoulos H; Fye KH; Sawada S; Becker MJ; Goldstein A; Talal N
Clin Exp Immunol; 1976 Dec; 26(3):563-73. PubMed ID: 795579
[TBL] [Abstract][Full Text] [Related]
19. Neuronal BC RNA Transport Impairments Caused by Systemic Lupus Erythematosus Autoantibodies.
Muslimov IA; Iacoangeli A; Eom T; Ruiz A; Lee M; Stephenson S; Ginzler EM; Tiedge H
J Neurosci; 2019 Sep; 39(39):7759-7777. PubMed ID: 31405929
[TBL] [Abstract][Full Text] [Related]
20. Raji cell assay for immune complexes. Evidence for detection of Raji-directed immunoglobulin G antibody in sera from patients with systemic lupus erythematosus.
Anderson CL; Stillman WS
J Clin Invest; 1980 Aug; 66(2):353-60. PubMed ID: 6995484
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
